RetroSense Therapeutics Welcomes Dr. Steven Bramer as Chief Development Officer

RetroSense Therapeutics Welcomes Dr. Steven Bramer as Chief Development Officer

10/4/2012 10:19:18 AM

ANN ARBOR, Mich.-- RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration welcomes Steven Bramer, PhD to its senior management team as Chief Development Officer.

Suggested Articles

With a new research team, outlook and more than a little help from the tech world, GSK has been quietly going about shoring up its pipeline.

The World Health Organization has called out Big Pharma for its dearth of antibiotic innovation amid a growing threat of antimicrobial resistance.

The trial hit its primary endpoint by the time of an interim analysis, enabling Chi-Med to stop the study and start work on a filing for approval.